Flesher James W, Lehner Andreas F
a Experimental Cancer Research Laboratory, Department of Molecular and Biomedical Pharmacology, University of Kentucky, College of Medicine , Lexington , KY , USA and.
b Section of Toxicology, Diagnostic Center for Population and Animal Health, College of Veterinary Medicine, Michigan State University , East Lansing , MI , USA.
Toxicol Mech Methods. 2016;26(3):151-79. doi: 10.3109/15376516.2015.1135223. Epub 2016 Feb 19.
The Unified Theory of PAH Carcinogenicity accommodates the activities of methylated and non-methylated polycyclic aromatic hydrocarbons (PAHs) and states that substitution of methyl groups on meso-methyl substituted PAHs with hydroxy, acetoxy, chloride, bromide or sulfuric acid ester groups imparts potent cancer producing properties. It incorporates specific predictions from past researchers on the mechanism of carcinogenesis by methyl-substituted hydrocarbons, including (1) requirement for metabolism to an ArCH2X type structure where X is a good leaving group and (2) biological substitution of a meso-methyl group at the most reactive center in non-methylated hydrocarbons. The Theory incorporates strong inferences of Fieser: (1) The mechanism of carcinogenesis involves a specific metabolic substitution of a hydrocarbon at its most reactive center and (2) Metabolic elimination of a carcinogen is a detoxifying process competitive with that of carcinogenesis and occurring by a different mechanism. According to this outlook, chemical or biochemical substitution of a methyl group at the reactive meso-position of non-methylated hydrocarbons is the first step in the mechanism of carcinogenesis for most, if not all, PAHs and the most potent metabolites of PAHs are to be found among the meso methyl-substituted hydrocarbons. Some PAHs and their known or potential metabolites and closely related compounds have been tested in rats for production of sarcomas at the site of subcutaneous injection and the results strongly support the specific predictions of the Unified Theory.
多环芳烃致癌性统一理论涵盖了甲基化和非甲基化多环芳烃(PAHs)的活性,并指出用羟基、乙酰氧基、氯、溴或硫酸酯基团取代中甲基取代的PAHs上的甲基会赋予强大的致癌特性。它纳入了过去研究人员对甲基取代烃致癌机制的具体预测,包括:(1)需要代谢为ArCH2X型结构,其中X是一个良好的离去基团;(2)在非甲基化烃中最具反应性的中心对中甲基进行生物取代。该理论纳入了菲泽的有力推断:(1)致癌机制涉及烃在其最具反应性的中心进行特定的代谢取代;(2)致癌物的代谢消除是一个与致癌作用竞争的解毒过程,且通过不同机制发生。根据这种观点,在非甲基化烃的反应性中位上进行甲基的化学或生化取代是大多数(如果不是全部)PAHs致癌机制的第一步,并且PAHs最有效的代谢产物将在中甲基取代的烃中找到。一些PAHs及其已知或潜在的代谢产物以及密切相关的化合物已在大鼠皮下注射部位进行肉瘤生成测试,结果有力地支持了统一理论的具体预测。